Virtual – CAR T and Bispecific Antibody Therapy for Multiple Myeloma

Join us for an educational session that begins with an introduction to the Multiple Myeloma Research Foundation (MMRF) and its mission, followed by an in-depth look at two innovative therapies: CAR T-cell therapy and bispecific antibodies. Learn what defines early and late relapsed/refractory multiple myeloma, explore available treatment options, and understand what patients can expect when undergoing CAR T or bispecific antibody therapy. The presentation will conclude with a Q&A.

Presented by: Grace Allison, RN, BSN, OCN, Patient Navigator at Multiple Myeloma Research Foundation

This lecture is in lieu of the Center’s monthly Multiple Myeloma Networking Group.

Registration closes at 2:00 pm on December 3rd.

An email with log-in instructions will be sent before the program.